Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Francis Knuettel II, M.B.A. | President, CEO, CFO, Treasurer, Secretary & Director | 107.5k | -- | 1966 |
| Dr. Eric Lang M.D. | Chief Medical Officer | 264.99k | -- | 1962 |
Channel Therapeutics Corporation
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 4
Description
Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the development and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain and acute and chronic eye pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.
Corporate Governance
Upcoming Events
Upcoming Events Information Not Available
Recent Events
December 11, 2024 at 12:00 AM UTC
POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
November 22, 2024 at 12:00 AM UTC
POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing